BlackRock Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $116K | Hold |
347
| – | – | ﹤0.01% | 2900 |
|
2016
Q3 | $104K | Sell |
347
-1,581
| -82% | -$474K | ﹤0.01% | 2935 |
|
2016
Q2 | $334K | Sell |
1,928
-451
| -19% | -$78.1K | ﹤0.01% | 2295 |
|
2016
Q1 | $533K | Sell |
2,379
-3
| -0.1% | -$672 | ﹤0.01% | 2002 |
|
2015
Q4 | $1.45M | Sell |
2,382
-60
| -2% | -$36.4K | ﹤0.01% | 1527 |
|
2015
Q3 | $1.26M | Buy |
2,442
+159
| +7% | +$81.8K | ﹤0.01% | 1532 |
|
2015
Q2 | $999K | Buy |
2,283
+2,205
| +2,827% | +$965K | ﹤0.01% | 1629 |
|
2015
Q1 | $28K | Buy |
78
+15
| +24% | +$5.39K | ﹤0.01% | 3355 |
|
2014
Q4 | $22K | Hold |
63
| – | – | ﹤0.01% | 3438 |
|
2014
Q3 | $19K | Hold |
63
| – | – | ﹤0.01% | 3460 |
|
2014
Q2 | $38K | Sell |
63
-5
| -7% | -$3.02K | ﹤0.01% | 3272 |
|
2014
Q1 | $46K | Buy |
+68
| New | +$46K | ﹤0.01% | 3248 |
|